Factor v leiden mutation and thrombotic occlusion of microsurgical anastomosis after free TRAM flap

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 2, 2010, Pages 199-203

  Handschin, A E ^a   Guggenheim, M ^a   Calcagni, M ^a   Kunzi W ^a   Giovanoli, P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Breast reconstruction; Thrombophilia; Thrombosis; TRAM

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; COUMARIN; DALTEPARIN; HEPARIN; UROKINASE;

ADULT; ANASTOMOSIS; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD TRANSFUSION; BODY MASS; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; DEEP VEIN THROMBOSIS; END TO END ANASTOMOSIS; FEMALE; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; MUSCLE FLAP; OBESITY; OXYGENATION; PECTORALIS MAJOR MUSCLE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RECTUS ABDOMINIS MUSCLE; RISK FACTOR; SKIN NECROSIS; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; VEIN THROMBOSIS; WOUND HEALING;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANASTOMOSIS, SURGICAL; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; BREAST NEOPLASMS; FACTOR V; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; REOPERATION; SURGICAL FLAPS; THROMBOLYTIC THERAPY; THROMBOPHILIA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 77949900770     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608325546     Document Type: Article

References (12)

1. Downes KJ, Glatt BS, Kanchwala SK, et al. Skin sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer. 2005 ; 103: 906-913.
2. Grotting JC, Beckenstein MS, Arkoulakis NS The art and science of autologous breast reconstruction. Breast J. 2003 ; 9: 350-360.
3. Howard MA, Polo K., Pusic AL, et al. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg. 2006 ; 177: 1381-1386.
4. Mehrara BJ, Santoro TD, Arcilla E., Watson JP, Shaw WW, da Lio AL Complications after microvascular breast recontruction: experience with 1195 flaps. Plast Reconstr Surg. 2006 ; 118: 1100-1109.
5. Segers K., Dahlbäck B., Nicolaes GAF. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007 ; 98: 530-542.
6. Bertina RM, Koelman BP, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 ; 369: 64-67.
7. Dahlbäck B. Inherited thrombophilia resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995 ; 85: 607-614.
8. Rees DC, Cox M., Clegg JB World distribution of factor V Leiden. Lancet. 1995 ; 346: 1133-1134.
9. Selber J., Kurichi JE, Vega SJ, Sonnag SS, Serletti JM Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg. 2006 ; 56: 492-497.
10. Arnljots B., Soederstroem T., Svensson H. No correlation between activated protein C resistance and free flap failures in 100 consecutive patients. Plast Reconstr Surg. 1998 ; 101: 1850-1853.
11. Ouriel K., Green RM, DeWeese JA, Cimino C. Acitvated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg. 1996 ; 23: 46-51.
12. Warnecke IC, Kretschmer F., Brüner S., Frerichs O., Fansa H. Hereditary thrombophilia in free microvascular flaps-a case report. Handchir Mikrochir Plast Chir. 2007 ; 39: 220-224.